Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A, Kleinschnitz C, Rauer S, Kuhle J, Stangel M, et al. Mult Scler. 2012 Oct 23. PMID: 23093485. Abstract CommentRecommendBookmarkWatch